Most Recent Additions*

Link

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.
Shih-Chun A Chu, Yi Hsiao, Chenwei Wang, Jennifer E Kyle, Raghav Jain, Yamei Deng, Marina A Gritsenko, Leanne E Henry, Jonathan T Lei, Yongchao Dou, Bahar Tercan, Zhiao Shi, Mahnoor N Gondal, Chia-Feng Tsai, John M Elizarraras, Rosalie K Chu, Fengchao Yu, Sunil K Joshi, Xiaojun Jing, Daniel A Polasky, Karl K Weitz, Ginny Xiaohe Li, Vanessa L Paurus, Chaevien S Clendinen, Athena A Schepmoes, Priscila M Lalli, Josie G Eder, Javier E Flores, Kelly G Stratton, James C Pino, Camilo Posso, Vladislav A Petyuk, Tyler J Sagendorf, Yuanwei Xu, Omar M Ibrahim, Ronald J Moore, Rui Zhao, Jin Chen, Matthew E Monroe, Mathangi Thiagarajan, Galen Hostetter, Chelsea Newton, Eunkyung An, Ana I Robles, Xu Zhang, Nathan J Edwards, Yin Lu, Hui Zhang, Haitham Abdelhakim, Paul D Piehowski, Mehdi Mesri, Richard D Smith, Chandan Kumar-Sinha, Cristina E Tognon, Jennifer Dunlap, Elie Traer, Li Ding, Jeffrey W Tyner, Arul M Chinnaiyan, Gilbert S Omenn, Karin D Rodland, Saravana M Dhanasekaran, Sara J C Gosline, Alexey I Nesvizhiskii, Bing Zhang, Tao Liu, and Marcin P Cieslik

Link

Colonoscopy utilization and persistent disparities in early onset colorectal cancer: A multistate, multi-institution nested case-control study.
Brian Diskin, Robyn A Husa, Saul A Castro, Staci J. Wendt, Ann Vita, Phil Robinson, Jennifer Rountree, Siavash Bolourani, Nicholas Ullman, Katiuscha Merath, and Anton J Bilchik

Link

Correction: Outcomes of hiatal closure with surgical gastropexy alone for large paraesophageal hernia without significant reflux.
John M Campbell, Megan L Ivy, Alexander S Farivar, Peter T White, Adam J Bograd, and Brian Louie

Link

Targeting Interleukin-6 for Treatment of CKD and Cardiovascular Disease.
Katherine Tuttle, David Z Cherney, Roberto Pecoits-Filho, Matteo Pirro, Kevin Yau, and Manisha Sahay

Link

Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis.
Johannes F E Mann, Sunil V Badve, Florian M M Baeres, Nicolas Belmar, Kirstine Brown-Frandsen, John B Buse, Helen M Colhoun, John E Deanfield, Mads D M Engelmann, G Kees Hovingh, Thomas Idorn, A Michael Lincoff, Ildiko Lingvay, Kenneth W Mahaffey, Darren K McGuire, Richard E Pratley, Søren Rasmussen, Peter Rossing, Naveed Sattar, Katherine Tuttle, and Vlado Perkovic

Link

Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomised, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial.
Désirée van der Heijde, Philip Mease, Carle Paul, Frank Behrens, Laure Gossec, Yuko Kaneko, Lihi Eder, Laura C Coates, Andrew E Pink, Weiguo Wan, Enrique R Soriano, Piotr Leszczyński, Jose U Scher, Atul Deodhar, Chahin Pachai, Janice Li, Xue Fan, Sahar Rabbat, Caroline Sardinas, Eleni Vritzali, John Vaile, and Joseph F Merola

Link

One-Year Outcomes After Endovascular Treatment for Large Acute Ischemic Stroke: The TESLA Randomized Clinical Trial.
Osama O Zaidat, Sami Al Kasab, Sunil A Sheth, Ansaar T Rai, Santiago Ortega-Gutierrez, Curtis A Given, Syed F Zaidi, Ramesh Grandhi, Hugo Cuellar-Saenz, Maxim Mokin, Jeffrey M Katz, Amer Alshekhlee, Muhammad A Taqi, Sameer A Ansari, Adnan H Siddiqui, Nobl Barazangi, Alberto Maud, Jawad Kirmani, Rishi Gupta, Dileep R Yavagal, Jason Tarpley, Dhruvil J Pandya, Marshall C Cress, Sushrut Dharmadhikari, Kaiz S Asif, Tareq Kass-Hout, Ajit S Puri, Nazli Janjua, Aniel Q Majjhoo, Aamir Badruddin, Alejandro M Spiotta, Parita Bhuva, Sergio Salazar-Marioni, Eugene Lin, Edgar A Samaniego, Murali K Kolikonda, Mouhammad A Jumaa, Charles B L M Majoie, Lucas Elijovich, Ashutosh Jadhav, Jasmine M Olvany, Zain Tariq, Scott Brown, Thanh N Nguyen, Daryl Gress, Diederik W J Dippel, Wade S Smith, and Albert J Yoo

Link

A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.
Rhianna Rich, Kelsey Laird, Prabha Siddarth, Brittany Youssef, Grace M Schwartz, Ashley Ramos, Karina Sergi, Micah Linton, Louie Schwartzberg, Daniel F Kelly, and Keith Heinzerling

Link

Rethinking Proteinuria: Resolution of Donor Derived EXT2-Associated Membranous Nephropathy Following Renal Transplantation.
Mike Fruscione, Devarsh Desai, Satoru Kudose, Yasir Qazi, Samuel Sultan, Kenneth Lieberman, and Michael J Goldstein

Link

A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma.
Jianguo Huang, Xingliang Liu, Warren Floyd, William Haugh, Zhaoyu Sun, Melissa Kasiewicz, Yaping Wu, Brian D. Piening, John Welle, Wesley K Rosales, Venkatesh Rajamanickam, So Young Kim, Eric S Xu, Lixia Luo, Yan Ma, Rutulkumar Patel, Ziqiang Zhang, Brady Bernard, William L. Redmond, Walter Urba, R Bryan Bell, and David G Kirsch

Link

Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature review.
Dafne Capelusnik, Clementina López-Medina, Casper Weber, Augusta Ortolan, Louise Falzon, Désirée van der Heijde, Robert Landewé, Philip Mease, Anna Molto, and Sofia Ramiro

Link

Nephrology in the Paradigm of Cardiovascular‑Kidney-Metabolic Health: Report of an ASN Initiative on Saving Kidneys, Hearts, and Lives.
Katherine Tuttle, Alessia Fornoni, Alan S Kliger, Bridget Kuehn, Daniel E Weiner, Melissa West, and Adeera Levin

Link

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.
Ross A Abrams, Kathryn A Winter, Karyn A Goodman, William F Regine, Howard P Safran, Chandan S Guha, Lisa A Kachnic, Michael T Gillin, Philip A Philip, Andrew M Lowy, Eileen O'Reilly, Jean-Luc Van Laethem, Samantha A Seaward, Abraham J Wu, Jennifer J Wu, Raid M Aljumaily, Thomas A DiPetrillo, Ravit Geva, Pramila Rani Anne, Darla K Liles, Diane C Ling, Alison Conlin, Jennifer Moughan, and Christopher H Crane

Link

Patient-reported outcomes in BRUIN CLL-321: A randomized phase 3 trial comparing pirtobrutinib to investigators choice of idelalisib plus rituximab or bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the post-cBTKi setting.
Paolo Ghia, Davide Rossi, Emmanuelle Ferrant, Fátima de la Cruz Vicente, Dai Maruyama, Versha Banerji, Patrick Cobb, Swathi Namburi, Richard Greil, Jeff P Sharman, Lisa M Hess, Nalin Payakachat, Naleen Raj Bhandari, Amy S Ruppert, Denise Wang, Paolo Abada, Angély Loubert, Kristin Creel, Carol Qiao, Yimei Han, Marisa Hill, Ching Ching Leow, Catherine C Coombs, and Paul M Barr

Link

Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: Novel insights from FOREMOST.
Laura C Coates, Dafna D Gladman, Joseph F Merola, Ulrich Mrowietz, April Armstrong, Xenofon Baraliakos, William Tillett, Mitsumasa Kishimoto, Jyotsna Reddy, Lichen Teng, Hamid Amouzadeh, Cynthia Deignan, Philip Mease, and Laure Gossec

*Updated as of 09/25/26.